1 |
Hu, C. P. and Li, Y. J. (2003) Research progress in pharmacological actions of evodiamine and rutaecarpine. Chem. Pharm. Bull. 10: 1084-1087
|
2 |
Dai, Y. Y, Liu, B. I. and Dou, C. G (2003) The pharmacological improvements of Evodia and its active components. J. Chin. Med. Mater. 4: 295-298
|
3 |
Kan, S. F., Huang, W. L., Lin, L. C. and Wang, P. S. (2004) Inhibitory effects of evodiamine on the growth of human prostate cancer cell line LNCaP. Int. J. Cancer 110: 641-651
DOI
ScienceOn
|
4 |
Shyu, K. G, Lin, S., Lee, C. C, Chen, E., Lin, L. C, Wang, B. W. and Tsai, S. C. (2006) Evodiamine inhibits in vitro angiogenesis: Implication for antitumorgenicity. Life Sci. 78: 2234-2243
DOI
ScienceOn
|
5 |
Houslay, M. D. and Tipton, K. F. (1976) Multiple forms of monoamine oxidase : fact and artefact. Life Sci. 19: 467-478
DOI
ScienceOn
|
6 |
Cross, A. J. and Joseph, M. H. (1981) The concurrent estimation of the major monoamine metabolites in human and non-human primate brain by HPLC with fluorescence and electrochemical detection. Life Sci. 28: 499-505
DOI
ScienceOn
|
7 |
Bembenek, M. E., Abell, C. W., Chrisey, L. A., Rozwa-dowska, M. D., Gessner, W. and Brossi, A. (1990) Inhibition of monoamine oxidase A and B by simple isoquinoline alkaloids: racemic and optically active 1,2,3,4-tetrahydro-, 3,4-dihydro-, and fully aromatic isoquinolines. J. Med. Chem. 33: 147-152
DOI
|
8 |
Ro, J. S., Lee, S. S., Lee, K. S. and Lee, M. K. (2001) Inhibition of type A monoamine oxidase by coptisine in mouse brain. Life Sci. 70: 639-645
DOI
ScienceOn
|
9 |
Lee, S. S, Yun-Choi, H. S., Kim, E. I. and Lee, M. K. (1999) Inhibition of monoamine oxidase by higenamine. Med. Sci. Res. 27: 71-72
|
10 |
Kraml, M. (1965) A rapid microfluorimetric determination of monoamine oxidase. Biochem. Pharmacol. 14: 1683-1685
|
11 |
Medvedev, A. E., Ivanov, A. S., Kamyshanskaya, N. S., Kirkel, A. Z., Moskvitina, T. A., Gorkin, V. Z., Li, N. Y and Marshakov, V. (1995) Interaction of indole derivatives with monoamine oxidase A and B. Studies on the structure-inhibitory activity relationship. Biochem. Mol. Biol. Int. 36: 113-122
|
12 |
Lowry, O. H., Rosebough, N. J., Fair, A. L. and Randall, R. J. (1951) Protein measurement with the folin phenol reagent. J. Biol. Chem. 193: 265-267
|
13 |
Naoi, M. and Nagatsu, T. (1986) Quinoline and quinaldine as naturally occurring inhibitors specific for type A monoamine oxidase. Life Sci. 40: 1075-1082
DOI
ScienceOn
|
14 |
Severina, I. S. (1979) Mechanism of selective inhibition by clorgyline and deprenyl of the possible nature of its form A and B., in Monoamine oxidase: structure, function and altered functions, de. by Singer, T. P., Von Korff, R. W. and Murphy, D. L., 169-183, Academic Press, New York
|
15 |
Naoi, M., Nomura, Y, Ishiki, R., Suzuki, H. and Nagatsu, T. (1988) 4-(O-Benzylphenoxy)-N-methylbutylamine (bife-melane) and other 4-(O-benzylphenoxy)-N-methylalky-lamines as new inhibitors of type and B monoamine oxidase. J. Neurochem. 50: 243-247
DOI
|
16 |
Lee, S. S., Lee, J. J, Cheong, M. J., Kim, Y H., Kim, Y, Yun, Y P., Lee, C. K. and Lee, M. K. (2001) Inhibitory effects of ethaverine, a homologue of papaverine, on monoamine oxidase activity in mouse brain. Biol. Pharm. Bull. 24: 838-840
DOI
ScienceOn
|
17 |
Shin, J. S., Kim, E. I, Kai, M. and Lee, M. K. (2000) Inhibition of dopamine biosynthesis by protoberberine alkaloids in PC12 cells. Neurochem. Res. 25: 363-368
DOI
ScienceOn
|
18 |
Nagatsu, T., Yamamoto, T. and Harada, M. (1970) Purification and properties of human brain mitochondrial monoamine oxidase. Enzymologia 39: 15-25
|
19 |
Shin, J. S., Lee, J. J., Kim, Y, Lee, C. K., Yun, Y P. and Lee, M. K. (2001) Inhibitory effects of ethaverine, a homologue of papaverine, on dopamine content in PC12 cells. Biol. Pharm. Bull. 24: 103-105
DOI
ScienceOn
|
20 |
Fowler, C. J., Ekstedt, B., Egashira, T., Kinemuchi, H. and Oreland, L. (1979) The interaction between human platelet monoamine oxidase, its monoamine substrates and oxygen. Biochem. Pharmacol. 28: 3063-3068
DOI
ScienceOn
|
21 |
Shin, J. S., Yun-Choi, H. S., Kim, E. I. and Lee, M. K. (1999) Inhibitory effects of higenamine on dopamine content in PC12 cells. Planta Med. 65: 452-455
DOI
ScienceOn
|
22 |
Yang, H. Y. T. and Neff, N. H. (1974) The monoamine oxidases of brain : selective inhibition with drugs and the consequences for the metabolism of the biogenic amines. J. Pharm. Exp. Ther. 189: 733-740
|
23 |
Lee, S. S., Kai, M. and Lee, M. K. (1999) Effects of natural isoquinoline alkaloids on monoamine oxidase activity in mouse brain: inhibition by berberine and palmatine. Med. Sci. Res. 27: 749-751
|
24 |
Lee, M. K, Hwang, B. Y, Lee, S. A., Oh, G J., Choi, W. H., Hong, S. S, Lee, K. S. and Ro, J. S. (2003) 1-Methyl-2-undecyl-4(1H)-quinolone as an irreversible and selective inhibitor of type B monoamine oxidase. Chem. Pharm. Bull. 51: 409-411
DOI
ScienceOn
|
25 |
Donnelly, C. H. and Murphy, D. L. (1977) Substrate- and inhibitor-related characteristics of human platelet monoamine oxidase. Biochem. Pharmacol. 26: 853-858
DOI
ScienceOn
|
26 |
Minami, M., .Maruyama, W., Dostert, P., Nagatsu, T. and Naoi, M. (1993) Inhibition of type A and B monoamine oxidase by 6,7-dihydroxy-1,2,3,4-tetrahydroisoquinolines and their N-methylated derivatives. J. Neural Transm. 92: 125-135
DOI
|
27 |
Shoji, N., Umeyama, A., Takemoto, T., Kajiwara, A., Ohizumi, Y. (1986) Isolation of evodiamine, a powerful cardiotonic principle, from Evodia rutaecarpa Bentham (Rutaceae). J. Pharmaceut. Sci. 75: 612-613
DOI
|
28 |
Naoi, M., Matsuura, S., Parvez, H., Takahashi, T, Hirata, Y, Minami, M. and Nagatsu, T. (1989) Oxidation of N-methyl-1,2,3,4-tetrahydroisoquinoline into the N-methyl-isoquino-linium ion by monoamine oxidase. J. Neurochem. 52: 653-655
DOI
|
29 |
Naoi, M. and Nagatsu, T. (1988) Inhibition of type A monoamine oxidase by methylquinolines and structurally related compounds. J. Neurochem. 50: 1105-1110
DOI
|
30 |
Riederer, P. and Youdim, M. B. H. (1986) Monoamine oxidase activity and monoamine metabolism in brains of parkinsonian patients treated with 1-deprenyl. J. Neurochem. 46: 1359-1365
DOI
|